Asger Lund, Md
Clinical trials sponsored by Asger Lund, Md, explained in plain language.
-
Could blocking GLP-1 stop dangerous low blood sugar in type 1 diabetes?
Knowledge-focused CompletedThis study looked at whether blocking a hormone called GLP-1 can help people with type 1 diabetes release glucagon, a natural safeguard against low blood sugar. Researchers gave 12 adults with type 1 diabetes a substance to block GLP-1 and measured their glucagon levels during lo…
Phase: NA • Sponsor: Asger Lund, MD • Aim: Knowledge-focused
Last updated May 26, 2026 09:32 UTC
-
New study unlocks clues to preventing low blood sugar in diabetes
Knowledge-focused CompletedThis study looked at how two natural substances—GIP (a gut hormone) and alanine (an amino acid from protein)—work together to trigger glucagon release, which raises blood sugar. Researchers tested 10 people with and without type 1 diabetes to see if combining them boosts glucagon…
Phase: NA • Sponsor: Asger Lund, MD • Aim: Knowledge-focused
Last updated May 26, 2026 09:21 UTC